Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Virginia Borges

Concepts (598)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
153
2026
2418
12.770
Why?
Pregnancy Complications, Neoplastic
18
2026
64
3.730
Why?
Postpartum Period
21
2026
377
2.820
Why?
Cancer Survivors
20
2025
348
2.390
Why?
Receptors, Estrogen
24
2026
406
2.240
Why?
Antineoplastic Agents, Hormonal
16
2026
196
2.090
Why?
Antineoplastic Combined Chemotherapy Protocols
22
2026
1998
1.970
Why?
Carcinoma, Ductal, Breast
10
2023
92
1.670
Why?
Mastectomy
17
2024
189
1.550
Why?
Protein Kinase Inhibitors
7
2025
983
1.390
Why?
Receptors, Progesterone
10
2026
242
1.240
Why?
Lactation
9
2021
193
1.220
Why?
Brain Neoplasms
11
2025
1325
1.200
Why?
Female
172
2026
79499
1.190
Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
61
1.090
Why?
Neoplasm Metastasis
13
2025
693
1.040
Why?
Adult
106
2026
41087
1.020
Why?
Breast
10
2021
155
0.990
Why?
Triple Negative Breast Neoplasms
8
2026
220
0.980
Why?
Trastuzumab
14
2026
119
0.930
Why?
Pregnancy
38
2026
7230
0.930
Why?
Oxazoles
8
2025
48
0.930
Why?
Antineoplastic Agents
12
2023
2219
0.900
Why?
Humans
181
2026
146342
0.890
Why?
Pyridines
9
2025
610
0.840
Why?
Neoplasm Recurrence, Local
16
2026
1160
0.830
Why?
Quinazolines
8
2025
267
0.830
Why?
Mammary Glands, Human
7
2020
71
0.820
Why?
Supreme Court Decisions
1
2022
12
0.740
Why?
Mammary Glands, Animal
9
2021
124
0.690
Why?
Carcinoma
3
2021
225
0.670
Why?
Neoplasm Staging
21
2026
1488
0.670
Why?
BRCA2 Protein
5
2024
69
0.670
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
34
0.650
Why?
Semaphorins
4
2025
37
0.640
Why?
Fertility Preservation
7
2025
57
0.640
Why?
Middle Aged
62
2026
36619
0.630
Why?
Prospective Studies
35
2026
8123
0.620
Why?
Neoadjuvant Therapy
7
2026
475
0.620
Why?
Prognosis
18
2026
4351
0.620
Why?
Breast Feeding
6
2025
447
0.600
Why?
Maternal Age
1
2020
129
0.600
Why?
Drug Resistance, Neoplasm
3
2022
893
0.590
Why?
Parity
8
2026
113
0.580
Why?
Antigens, CD
6
2025
560
0.580
Why?
Chemotherapy, Adjuvant
16
2026
429
0.580
Why?
Young Adult
40
2026
14330
0.570
Why?
Estradiol
5
2019
517
0.560
Why?
Biomarkers, Tumor
13
2026
1339
0.550
Why?
Extracellular Vesicles
1
2020
176
0.530
Why?
Carcinoma in Situ
3
2022
45
0.530
Why?
Disease-Free Survival
11
2026
778
0.520
Why?
Lymphatic Metastasis
10
2021
335
0.510
Why?
Neoplasms, Second Primary
3
2024
103
0.490
Why?
Quality of Life
12
2025
3200
0.480
Why?
Cyclooxygenase 2
5
2020
166
0.460
Why?
Mutation
11
2025
4093
0.420
Why?
Capecitabine
5
2023
56
0.420
Why?
Melanoma
4
2018
765
0.410
Why?
Skin Neoplasms
4
2013
806
0.410
Why?
Aromatase Inhibitors
6
2019
81
0.410
Why?
Liver Neoplasms
4
2016
776
0.410
Why?
Carcinoma, Lobular
2
2012
59
0.400
Why?
Mastectomy, Segmental
6
2022
107
0.400
Why?
Combined Modality Therapy
10
2023
1271
0.390
Why?
Puerperal Disorders
2
2014
35
0.390
Why?
BRCA1 Protein
4
2024
84
0.380
Why?
Stromal Cells
3
2013
123
0.360
Why?
Tumor Suppressor Protein p53
2
2021
530
0.350
Why?
Genes, BRCA2
3
2026
33
0.340
Why?
Genes, BRCA1
3
2026
45
0.340
Why?
Anxiety
7
2022
1125
0.340
Why?
Resistance Training
2
2025
186
0.330
Why?
Neoplasms
7
2026
2954
0.330
Why?
Nevus, Pigmented
1
2011
35
0.330
Why?
Antibodies, Monoclonal, Humanized
8
2026
992
0.330
Why?
Sexual Partners
3
2022
195
0.330
Why?
Epithelial Cells
6
2018
1119
0.320
Why?
Neoplasm Invasiveness
6
2020
504
0.320
Why?
Aged
31
2026
26432
0.310
Why?
Social Support
4
2025
646
0.310
Why?
Fertility
5
2025
174
0.310
Why?
Cohort Studies
13
2026
6077
0.310
Why?
Tamoxifen
7
2021
193
0.310
Why?
Premenopause
6
2026
130
0.300
Why?
Estrogens
4
2015
364
0.300
Why?
Cyclophosphamide
5
2020
275
0.290
Why?
Radiosurgery
3
2021
398
0.290
Why?
Adjuvants, Immunologic
2
2022
245
0.290
Why?
Gene Expression Profiling
8
2020
1792
0.290
Why?
Thrombophilia
1
2009
89
0.280
Why?
Risk Factors
17
2024
10921
0.280
Why?
T-Lymphocytes
6
2018
2012
0.280
Why?
Patient Acceptance of Health Care
2
2025
881
0.280
Why?
GPI-Linked Proteins
4
2025
81
0.280
Why?
Incidence
7
2024
2936
0.270
Why?
Cell Line, Tumor
10
2025
3545
0.270
Why?
Quinolines
3
2025
191
0.270
Why?
Mice
21
2025
18297
0.270
Why?
Heterozygote
2
2026
311
0.270
Why?
Animals
31
2025
38107
0.260
Why?
Gene Expression Regulation, Neoplastic
4
2021
1432
0.260
Why?
Breast Neoplasms, Male
2
2018
29
0.260
Why?
Doxorubicin
5
2020
416
0.260
Why?
Follow-Up Studies
7
2026
5439
0.260
Why?
Employment
2
2019
180
0.260
Why?
Kaplan-Meier Estimate
4
2020
970
0.260
Why?
Appetite
2
2025
80
0.260
Why?
Decision Making
4
2022
993
0.250
Why?
Lymphocytes, Tumor-Infiltrating
2
2026
156
0.250
Why?
Maytansine
2
2018
18
0.240
Why?
Myeloid-Derived Suppressor Cells
2
2018
78
0.240
Why?
Estrogen Receptor alpha
3
2025
154
0.240
Why?
Time Factors
7
2020
7109
0.230
Why?
Adaptation, Psychological
2
2022
721
0.230
Why?
Delayed Diagnosis
1
2026
102
0.230
Why?
Disease Management
3
2021
651
0.230
Why?
Estrogen Receptor Antagonists
1
2025
4
0.230
Why?
Reproductive History
2
2015
12
0.220
Why?
Ovarian Reserve
1
2025
19
0.220
Why?
CD8-Positive T-Lymphocytes
5
2023
931
0.220
Why?
Germ-Line Mutation
1
2026
180
0.220
Why?
Primary Ovarian Insufficiency
1
2025
40
0.220
Why?
Hematopoietic Stem Cell Transplantation
1
2011
704
0.220
Why?
Energy Intake
2
2025
507
0.220
Why?
Dimethyl Sulfoxide
1
2005
42
0.220
Why?
Mammography
3
2025
175
0.220
Why?
Cell Plasticity
1
2025
37
0.210
Why?
Macrophages
4
2018
1532
0.210
Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
111
0.210
Why?
Proportional Hazards Models
2
2022
1331
0.210
Why?
Transforming Growth Factor beta1
1
2025
176
0.210
Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
175
0.210
Why?
Adolescent
20
2024
22557
0.200
Why?
Genetic Predisposition to Disease
6
2024
2488
0.200
Why?
Time-to-Treatment
1
2026
257
0.200
Why?
Bupropion
1
2004
47
0.200
Why?
Disease Progression
10
2020
2867
0.200
Why?
Reproductive Techniques, Assisted
1
2024
48
0.200
Why?
Lymph Nodes
3
2019
511
0.200
Why?
Treatment Outcome
10
2026
11821
0.200
Why?
Drug Administration Schedule
3
2018
790
0.200
Why?
Tumor Microenvironment
7
2026
747
0.190
Why?
Diarrhea
3
2019
190
0.190
Why?
Multiple Sclerosis
1
2008
435
0.190
Why?
Immunotherapy
3
2025
671
0.190
Why?
Cell Proliferation
5
2021
2502
0.190
Why?
Liver
3
2020
1864
0.190
Why?
Disease Models, Animal
5
2020
4580
0.190
Why?
Pharmaceutical Preparations
1
2005
172
0.190
Why?
Age Factors
9
2021
3347
0.190
Why?
Hypertension, Pregnancy-Induced
1
2023
69
0.190
Why?
Aurora Kinase A
2
2019
57
0.180
Why?
Women's Health
1
2024
317
0.180
Why?
Chromatography, Liquid
1
2004
453
0.180
Why?
Pilonidal Sinus
1
2001
4
0.180
Why?
Condylomata Acuminata
1
2001
7
0.180
Why?
Genomic Instability
1
2022
64
0.180
Why?
Antineoplastic Agents, Immunological
3
2019
200
0.180
Why?
Retrospective Studies
11
2026
17438
0.170
Why?
Drug Monitoring
2
2019
399
0.170
Why?
Proteomics
2
2020
1203
0.170
Why?
Hematopoiesis
1
2022
195
0.170
Why?
Nausea
2
2018
111
0.170
Why?
Piperazines
1
2023
368
0.170
Why?
Artificial Intelligence
1
2026
389
0.170
Why?
Aged, 80 and over
7
2025
8391
0.160
Why?
Genetic Testing
3
2026
492
0.160
Why?
Ki-67 Antigen
2
2019
120
0.160
Why?
Mass Spectrometry
1
2004
729
0.160
Why?
Dyspareunia
1
2020
8
0.160
Why?
Mice, Inbred BALB C
6
2019
1244
0.160
Why?
Body Image
3
2020
96
0.160
Why?
Cancer Care Facilities
1
2020
48
0.160
Why?
Biopsy
4
2018
1075
0.150
Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.150
Why?
Ibuprofen
2
2018
87
0.150
Why?
Risk
3
2013
920
0.150
Why?
Neoplasm Grading
5
2021
313
0.150
Why?
Mice, Inbred NOD
1
2021
598
0.150
Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1195
0.150
Why?
Benzodiazepines
1
2021
158
0.150
Why?
p21-Activated Kinases
1
2019
13
0.150
Why?
Bone Neoplasms
2
2016
272
0.150
Why?
Sexual Health
1
2020
67
0.150
Why?
Cell Adhesion
1
2020
447
0.140
Why?
Fatigue
2
2018
363
0.140
Why?
Pregnancy Outcome
4
2026
503
0.140
Why?
Immunohistochemistry
8
2019
1712
0.140
Why?
Parkinson Disease
2
2015
614
0.140
Why?
Sexual Dysfunctions, Psychological
1
2019
29
0.140
Why?
Carcinoma, Ductal
2
2011
10
0.140
Why?
Receptor, trkB
1
2019
39
0.140
Why?
Germ Cells
3
2024
67
0.140
Why?
Lymphangiogenesis
2
2018
28
0.140
Why?
Response Evaluation Criteria in Solid Tumors
1
2018
21
0.140
Why?
Cell Communication
1
2020
327
0.140
Why?
Pyrazoles
3
2018
517
0.140
Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
14
0.140
Why?
Stress, Psychological
2
2025
1171
0.140
Why?
Tryptophan Oxygenase
1
2018
33
0.140
Why?
Ipilimumab
1
2018
44
0.140
Why?
Neoplasm Proteins
2
2020
444
0.140
Why?
Progesterone
2
2025
214
0.140
Why?
Sexual Dysfunction, Physiological
1
2019
74
0.130
Why?
Parenting
1
2022
309
0.130
Why?
Brain-Derived Neurotrophic Factor
1
2019
155
0.130
Why?
Cisplatin
1
2020
347
0.130
Why?
Vitamin D
1
2021
402
0.130
Why?
Area Under Curve
1
2018
335
0.130
Why?
Cross-Sectional Studies
7
2025
5899
0.130
Why?
Tretinoin
1
2018
115
0.130
Why?
United States
8
2025
16136
0.130
Why?
Receptors, Antigen, T-Cell
2
2023
677
0.130
Why?
Immunity, Mucosal
1
2018
97
0.130
Why?
T-Lymphocytes, Regulatory
2
2018
415
0.130
Why?
Patient Care Management
1
2017
54
0.130
Why?
Programmed Cell Death 1 Receptor
1
2019
268
0.120
Why?
Tryptophan
1
2018
184
0.120
Why?
Granulocytes
1
2017
82
0.120
Why?
Socioeconomic Factors
5
2021
1327
0.120
Why?
Case-Control Studies
3
2020
3647
0.120
Why?
Drug Delivery Systems
2
2010
377
0.120
Why?
Global Health
1
2020
403
0.120
Why?
Carcinoma, Squamous Cell
1
2001
628
0.120
Why?
Protein-Tyrosine Kinases
1
2019
429
0.120
Why?
Metaplasia
1
2016
54
0.120
Why?
Cell Transformation, Neoplastic
3
2015
314
0.120
Why?
Pancreatic Cyst
1
2017
50
0.120
Why?
Surveys and Questionnaires
8
2024
6073
0.120
Why?
Radiotherapy, Image-Guided
1
2016
40
0.120
Why?
Prostatic Neoplasms
2
2021
972
0.120
Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
Why?
Dyskinesia, Drug-Induced
1
1995
14
0.120
Why?
Cellular Microenvironment
1
2016
94
0.110
Why?
Epithelium
2
2015
295
0.110
Why?
Levodopa
1
1995
40
0.110
Why?
Antiparkinson Agents
1
1995
41
0.110
Why?
Cytophagocytosis
1
2015
5
0.110
Why?
Prophylactic Surgical Procedures
1
2015
7
0.110
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
344
0.110
Why?
Adherens Junctions
1
2015
24
0.110
Why?
Transforming Growth Factor beta3
1
2015
15
0.110
Why?
Depression
3
2020
1575
0.110
Why?
Lung Neoplasms
2
2021
2675
0.110
Why?
Phosphoproteins
2
2015
320
0.110
Why?
Paracrine Communication
1
2015
67
0.110
Why?
Rats
6
2021
5586
0.110
Why?
Menarche
1
2015
53
0.110
Why?
Lymphocyte Activation
3
2017
1137
0.110
Why?
Chronic Pain
1
2019
304
0.110
Why?
Risk Reduction Behavior
1
2016
220
0.110
Why?
Spleen
1
2017
503
0.110
Why?
Lymph Node Excision
2
2021
174
0.110
Why?
Microfilament Proteins
1
2015
136
0.110
Why?
Hodgkin Disease
1
2016
173
0.110
Why?
Pyrimidines
1
2018
532
0.110
Why?
Survival Analysis
4
2021
1378
0.100
Why?
Gastrointestinal Microbiome
1
2022
769
0.100
Why?
Peptide YY
2
2025
28
0.100
Why?
Survivors
3
2023
526
0.100
Why?
Aging
1
2025
1996
0.100
Why?
Odds Ratio
4
2020
1077
0.100
Why?
Extracellular Matrix
2
2016
565
0.100
Why?
Mammary Neoplasms, Animal
1
2014
35
0.100
Why?
Amenorrhea
1
2014
35
0.100
Why?
Carbon Cycle
1
2014
13
0.100
Why?
Ghrelin
2
2025
42
0.100
Why?
Administration, Oral
3
2025
872
0.100
Why?
Calcium-Binding Proteins
1
2015
221
0.100
Why?
Multivariate Analysis
2
2019
1543
0.100
Why?
Brain Edema
1
2014
63
0.100
Why?
Monocytes
1
2017
538
0.100
Why?
Droughts
1
2014
32
0.100
Why?
Disability Evaluation
1
2015
297
0.100
Why?
Collagen
2
2021
460
0.100
Why?
Atmosphere
1
2014
52
0.100
Why?
Spouses
1
2015
107
0.100
Why?
Tremor
1
1994
98
0.100
Why?
Astrocytes
1
2015
229
0.100
Why?
Male
20
2022
73396
0.100
Why?
Neoplastic Cells, Circulating
2
2016
81
0.100
Why?
Signal Transduction
4
2020
5246
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
974
0.100
Why?
Trans-Activators
1
2015
372
0.100
Why?
Antigens, Differentiation, Myelomonocytic
3
2019
66
0.090
Why?
Nitriles
1
2014
212
0.090
Why?
Infertility, Female
1
2014
124
0.090
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
27
0.090
Why?
Lymphatic Vessels
3
2019
64
0.090
Why?
Triazoles
1
2014
190
0.090
Why?
Postural Balance
1
2015
249
0.090
Why?
Myeloid Cells
1
2013
149
0.090
Why?
Apoptosis
3
2019
2439
0.090
Why?
Drug Design
1
2013
180
0.090
Why?
Logistic Models
5
2016
2126
0.090
Why?
Genes, Bacterial
1
2012
151
0.090
Why?
Genome-Wide Association Study
1
2019
1537
0.090
Why?
Cardiovascular Diseases
1
2024
2219
0.090
Why?
Live Birth
2
2023
81
0.090
Why?
Interpersonal Relations
1
2015
387
0.090
Why?
Analgesics, Opioid
1
2021
1221
0.090
Why?
Fibrillar Collagens
1
2011
15
0.090
Why?
Wound Healing
1
2014
354
0.090
Why?
Mice, Inbred C57BL
6
2019
6034
0.090
Why?
Real-Time Polymerase Chain Reaction
1
2012
334
0.080
Why?
Double-Blind Method
3
2021
2070
0.080
Why?
Membrane Proteins
2
2015
1130
0.080
Why?
Patient Participation
1
2015
457
0.080
Why?
Transcriptome
2
2021
1068
0.080
Why?
Antigen Presentation
2
2018
209
0.080
Why?
B7-H1 Antigen
2
2026
245
0.080
Why?
Biopsy, Needle
1
2011
183
0.080
Why?
Streptococcus agalactiae
1
2012
118
0.080
Why?
Xenograft Model Antitumor Assays
3
2020
930
0.080
Why?
Estrogen Antagonists
1
2010
37
0.080
Why?
Sexual Behavior
1
2014
490
0.080
Why?
Adenocarcinoma
2
2015
927
0.080
Why?
Cell Fusion
2
2006
47
0.070
Why?
Radiotherapy, Adjuvant
2
2021
222
0.070
Why?
Pregnancy Trimester, Second
1
2009
91
0.070
Why?
Clinical Trials as Topic
3
2017
1064
0.070
Why?
Sentinel Lymph Node Biopsy
3
2021
118
0.070
Why?
Reference Standards
2
2012
176
0.070
Why?
Cell Movement
3
2019
951
0.070
Why?
Glatiramer Acetate
1
2008
11
0.070
Why?
Interferon beta-1a
1
2008
12
0.070
Why?
Mucin-1
1
2009
29
0.070
Why?
Pregnancy Trimester, First
1
2009
140
0.070
Why?
Macrophage Activation
1
2010
182
0.070
Why?
In Situ Hybridization, Fluorescence
3
2019
334
0.070
Why?
Clinical Trials, Phase I as Topic
2
2020
49
0.070
Why?
Apoptosis Regulatory Proteins
1
2009
186
0.070
Why?
Dose-Response Relationship, Drug
3
2018
2022
0.070
Why?
Rats, Sprague-Dawley
4
2016
2537
0.070
Why?
Metalloproteases
1
2008
42
0.070
Why?
Interferon-beta
1
2008
90
0.070
Why?
Extracellular Matrix Proteins
1
2009
156
0.070
Why?
Sensitivity and Specificity
3
2013
1998
0.070
Why?
Gonadal Steroid Hormones
1
2009
143
0.070
Why?
Paclitaxel
2
2026
260
0.070
Why?
Phenotype
3
2026
3206
0.070
Why?
Age of Onset
2
2021
558
0.060
Why?
Intercellular Signaling Peptides and Proteins
1
2009
372
0.060
Why?
Cell Cycle
2
2021
595
0.060
Why?
Disease Susceptibility
1
2009
339
0.060
Why?
Genomics
2
2023
853
0.060
Why?
Maximum Tolerated Dose
2
2018
217
0.060
Why?
Gene Knockdown Techniques
2
2020
335
0.060
Why?
ErbB Receptors
3
2017
636
0.060
Why?
Bridged-Ring Compounds
1
2026
31
0.060
Why?
Mice, Nude
3
2015
668
0.060
Why?
Sternum
1
2006
26
0.060
Why?
Antibodies, Monoclonal
3
2009
1512
0.060
Why?
Cell Survival
2
2020
1105
0.060
Why?
Cells, Cultured
3
2019
4118
0.060
Why?
Taxoids
1
2026
115
0.060
Why?
Polymerase Chain Reaction
2
2016
1031
0.060
Why?
Risk Assessment
3
2026
3712
0.060
Why?
Membrane Glycoproteins
2
2019
495
0.060
Why?
Ovariectomy
2
2019
164
0.060
Why?
Keratins
1
2026
57
0.060
Why?
Postmenopause
2
2005
394
0.060
Why?
HIV Infections
1
2001
3215
0.060
Why?
Axilla
2
2021
51
0.060
Why?
Parturition
1
2026
72
0.060
Why?
Child
6
2022
22693
0.060
Why?
Models, Biological
2
2012
1761
0.060
Why?
Forkhead Transcription Factors
2
2018
209
0.060
Why?
Prolactin
1
2025
88
0.060
Why?
Mammaplasty
2
2021
150
0.050
Why?
Fear
2
2021
373
0.050
Why?
Anti-Mullerian Hormone
1
2025
62
0.050
Why?
Mice, Knockout
2
2025
3125
0.050
Why?
Thyrotropin
1
2025
120
0.050
Why?
PTEN Phosphohydrolase
1
2026
166
0.050
Why?
Infant, Newborn
2
2023
6460
0.050
Why?
Dendritic Cells
2
2005
509
0.050
Why?
Analysis of Variance
3
2014
1298
0.050
Why?
Enzyme Inhibitors
1
2008
823
0.050
Why?
Solubility
1
2005
240
0.050
Why?
Congresses as Topic
1
2026
226
0.050
Why?
Neoplastic Processes
1
2023
5
0.050
Why?
Ovulation Induction
1
2024
68
0.050
Why?
Cancer Vaccines
1
2005
161
0.050
Why?
Follicle Stimulating Hormone
1
2025
265
0.050
Why?
Weaning
2
2016
50
0.050
Why?
Epithelial-Mesenchymal Transition
1
2025
219
0.050
Why?
North America
1
2024
300
0.050
Why?
Celecoxib
2
2014
41
0.050
Why?
Cryopreservation
1
2024
115
0.050
Why?
Withholding Treatment
1
2023
77
0.050
Why?
Sensation
1
2022
56
0.050
Why?
Peptides
1
2008
992
0.050
Why?
DNA End-Joining Repair
1
2022
22
0.050
Why?
Mucins
1
2022
75
0.040
Why?
Cost of Illness
1
2024
323
0.040
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
330
0.040
Why?
Chromosome Aberrations
1
2022
167
0.040
Why?
Colorado
3
2020
4595
0.040
Why?
Psychiatric Status Rating Scales
2
2015
522
0.040
Why?
Evidence-Based Medicine
1
2025
731
0.040
Why?
Genes, p53
1
2021
56
0.040
Why?
Chemoradiotherapy, Adjuvant
1
2021
44
0.040
Why?
Multiple Myeloma
1
2005
310
0.040
Why?
Clinical Trials, Phase III as Topic
1
2021
116
0.040
Why?
Hypertrophy
1
2021
127
0.040
Why?
Placebos
1
2021
192
0.040
Why?
In Situ Hybridization
1
2001
317
0.040
Why?
Reproducibility of Results
2
2012
3416
0.040
Why?
Protective Agents
1
2021
43
0.040
Why?
Societies, Medical
1
2025
907
0.040
Why?
Referral and Consultation
1
2007
881
0.040
Why?
Immunity
1
2021
141
0.040
Why?
Neoplasm, Residual
1
2021
143
0.040
Why?
Hormones
1
2021
134
0.040
Why?
DNA Replication
1
2022
248
0.040
Why?
Hospitals, University
1
2021
178
0.040
Why?
Arm
1
2021
111
0.040
Why?
CD4-Positive T-Lymphocytes
2
2019
1150
0.040
Why?
Pregnancy Rate
1
2020
83
0.040
Why?
Early Detection of Cancer
1
2026
506
0.040
Why?
Cross-Over Studies
1
2022
615
0.040
Why?
DNA Repair
1
2022
255
0.040
Why?
Flow Cytometry
3
2013
1163
0.040
Why?
Morbidity
1
2021
319
0.040
Why?
Confidence Intervals
1
2020
329
0.040
Why?
Consolidation Chemotherapy
1
2019
11
0.040
Why?
Multicenter Studies as Topic
1
2021
417
0.040
Why?
Age Distribution
1
2020
399
0.040
Why?
Kidney Neoplasms
1
2004
419
0.040
Why?
SEER Program
1
2021
233
0.040
Why?
Patient Reported Outcome Measures
1
2024
516
0.040
Why?
DNA, Viral
1
2001
354
0.040
Why?
Base Sequence
2
2016
2123
0.040
Why?
Vaginal Diseases
1
2019
19
0.040
Why?
Fibronectins
1
2020
136
0.040
Why?
Unemployment
1
2019
43
0.040
Why?
Severity of Illness Index
2
2019
2921
0.040
Why?
Leuprolide
1
2019
21
0.040
Why?
Terminology as Topic
1
2021
253
0.040
Why?
Mammary Neoplasms, Experimental
1
2019
61
0.040
Why?
Sulfonamides
2
2014
594
0.040
Why?
Interleukin-10
2
2014
310
0.030
Why?
Crosses, Genetic
1
2018
120
0.030
Why?
Weight Gain
1
2022
562
0.030
Why?
Hot Flashes
1
2019
92
0.030
Why?
Maintenance Chemotherapy
1
2018
41
0.030
Why?
Factor Analysis, Statistical
1
2019
298
0.030
Why?
Integrins
1
2018
88
0.030
Why?
Body Weight
1
2022
968
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2019
157
0.030
Why?
Kynurenine
1
2018
114
0.030
Why?
Antimetabolites, Antineoplastic
1
2018
108
0.030
Why?
Contraceptives, Oral
1
2017
37
0.030
Why?
Behavior
1
2018
90
0.030
Why?
RNA, Small Interfering
1
2020
633
0.030
Why?
Patient Satisfaction
1
2021
706
0.030
Why?
Dietary Supplements
1
2021
587
0.030
Why?
Educational Status
1
2019
466
0.030
Why?
Tumor Escape
1
2017
50
0.030
Why?
Drug Therapy, Combination
1
2019
1036
0.030
Why?
Weight Loss
1
2022
858
0.030
Why?
National Cancer Institute (U.S.)
1
2016
56
0.030
Why?
Cell Count
1
2017
315
0.030
Why?
Emulsions
1
2016
58
0.030
Why?
Stress Disorders, Post-Traumatic
1
2024
892
0.030
Why?
Alleles
1
2019
907
0.030
Why?
Population Surveillance
1
2019
481
0.030
Why?
Immune Tolerance
1
2018
386
0.030
Why?
Radiotherapy Dosage
1
2016
289
0.030
Why?
Immunophenotyping
1
2017
324
0.030
Why?
Antigens, Differentiation
1
2015
75
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2016
150
0.030
Why?
Body Mass Index
2
2015
2458
0.030
Why?
Directive Counseling
1
2015
48
0.030
Why?
Hybrid Cells
2
2005
47
0.030
Why?
Reproduction
1
2016
209
0.030
Why?
Molecular Targeted Therapy
1
2018
447
0.030
Why?
Biomarkers
2
2021
4340
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1763
0.030
Why?
Medication Adherence
1
2019
535
0.030
Why?
Amyloid Precursor Protein Secretases
1
2015
80
0.030
Why?
Medicare
1
2021
920
0.030
Why?
Posture
1
2015
182
0.030
Why?
Tropical Climate
1
2014
13
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
266
0.030
Why?
Genotype
1
2019
1879
0.030
Why?
Biota
1
2014
28
0.030
Why?
Cognition
1
2022
1292
0.030
Why?
Leukocyte Common Antigens
1
2014
86
0.030
Why?
Dinoprostone
1
2014
179
0.030
Why?
Trees
1
2014
61
0.020
Why?
Fresh Water
1
2014
53
0.020
Why?
STAT5 Transcription Factor
1
2013
51
0.020
Why?
Tumor Burden
1
2015
326
0.020
Why?
Rain
1
2014
38
0.020
Why?
Terminal Care
1
2018
284
0.020
Why?
Biomass
1
2014
96
0.020
Why?
Blood Cell Count
1
2013
56
0.020
Why?
Carbon Monoxide
1
2014
82
0.020
Why?
Brazil
1
2014
179
0.020
Why?
Dermoscopy
1
2013
11
0.020
Why?
Immunoblotting
1
2014
294
0.020
Why?
Clinical Decision-Making
1
2017
365
0.020
Why?
Massachusetts
1
2014
178
0.020
Why?
Necrosis
1
2014
243
0.020
Why?
Family Health
1
1994
194
0.020
Why?
Oncogenes
1
2013
113
0.020
Why?
Wnt Signaling Pathway
1
2015
211
0.020
Why?
Fires
1
2014
76
0.020
Why?
beta Catenin
1
2015
250
0.020
Why?
Lipopolysaccharide Receptors
1
2013
88
0.020
Why?
Photosynthesis
1
2014
104
0.020
Why?
Child, Preschool
2
2021
11913
0.020
Why?
Karyotyping
1
2012
106
0.020
Why?
Magnetic Resonance Imaging
1
2025
3926
0.020
Why?
Immune System
1
2014
181
0.020
Why?
Adiposity
1
2017
533
0.020
Why?
Gonadotropin-Releasing Hormone
1
2014
215
0.020
Why?
Accidental Falls
1
2015
227
0.020
Why?
Observer Variation
1
2013
356
0.020
Why?
Endothelial Cells
1
2018
876
0.020
Why?
Cell Division
1
2013
736
0.020
Why?
Opioid-Related Disorders
1
2021
634
0.020
Why?
Carbon Dioxide
1
2014
228
0.020
Why?
Comorbidity
1
2017
1665
0.020
Why?
Menopause
1
2015
328
0.020
Why?
Carcinogenesis
1
2013
226
0.020
Why?
Calibration
1
2012
154
0.020
Why?
Recurrence
1
2015
1133
0.020
Why?
Polymorphism, Single Nucleotide
1
2019
2240
0.020
Why?
Interferon-gamma
2
2005
781
0.020
Why?
Seasons
1
2014
540
0.020
Why?
RNA, Bacterial
1
2012
183
0.020
Why?
Tomography, X-Ray Computed
2
2015
2786
0.020
Why?
Cell Differentiation
1
2018
1982
0.020
Why?
Cell Line
1
2016
2814
0.020
Why?
Mice, SCID
1
2011
360
0.020
Why?
Genome, Human
1
2013
431
0.020
Why?
Photochemotherapy
1
2010
39
0.020
Why?
Self Report
1
2015
870
0.020
Why?
Universities
1
2013
451
0.020
Why?
Gene Expression Regulation, Bacterial
1
2012
340
0.020
Why?
Hypertension
1
2018
1272
0.020
Why?
Microscopy, Confocal
1
2010
322
0.020
Why?
Feasibility Studies
1
2014
1135
0.020
Why?
Matrix Metalloproteinases
1
2010
95
0.020
Why?
Survival Rate
1
2014
2092
0.020
Why?
Keratin-19
1
2009
4
0.020
Why?
Immunomagnetic Separation
1
2009
4
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
21
0.020
Why?
Palliative Care
1
2018
1032
0.020
Why?
Dose-Response Relationship, Immunologic
1
2009
77
0.020
Why?
Diagnosis, Differential
1
2013
1503
0.020
Why?
Blotting, Western
1
2011
1177
0.020
Why?
Vinblastine
1
2009
75
0.020
Why?
Physician-Patient Relations
1
2014
597
0.020
Why?
Species Specificity
1
2010
543
0.020
Why?
ADAM12 Protein
1
2008
4
0.020
Why?
Flavonoids
1
2009
85
0.020
Why?
Estrogen Receptor Modulators
1
2008
14
0.020
Why?
Perilipin-1
1
2008
16
0.020
Why?
S100 Proteins
1
2008
33
0.020
Why?
Sex Factors
1
1994
2107
0.020
Why?
ADAM Proteins
1
2008
65
0.020
Why?
Androstadienes
1
2008
77
0.020
Why?
Perimenopause
1
2008
69
0.020
Why?
DNA Primers
1
2009
487
0.020
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
139
0.020
Why?
Matrix Metalloproteinase 9
1
2008
128
0.020
Why?
Radiotherapy
1
2008
209
0.020
Why?
Prevalence
1
2014
2861
0.020
Why?
Gene Expression
1
2012
1463
0.020
Why?
Piperidines
1
2009
225
0.020
Why?
Chi-Square Distribution
1
2008
517
0.020
Why?
Cluster Analysis
1
2008
496
0.020
Why?
Precancerous Conditions
1
2008
162
0.020
Why?
Protein Structure, Tertiary
1
2009
834
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2008
752
0.010
Why?
Pleural Effusion
1
2006
59
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2005
49
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2005
39
0.010
Why?
Receptors, CCR7
1
2005
32
0.010
Why?
Receptors, Chemokine
1
2005
47
0.010
Why?
Antigens, CD34
1
2005
89
0.010
Why?
Interleukin-12
1
2005
115
0.010
Why?
Hemocyanins
1
2004
61
0.010
Why?
Positron-Emission Tomography
1
2006
343
0.010
Why?
Carrier Proteins
1
2008
728
0.010
Why?
Coculture Techniques
1
2004
245
0.010
Why?
Patient Care Planning
1
2005
170
0.010
Why?
Cell Separation
1
2004
300
0.010
Why?
Cell Nucleus
1
2006
584
0.010
Why?
Tumor Cells, Cultured
1
2004
882
0.010
Why?
Brain
1
2014
2991
0.010
Why?
Pilot Projects
1
2003
1888
0.010
Why?
Vaccination
1
2004
1449
0.010
Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)